Ovid Therapeutics
OVID
#8767
Rank
โ‚น7.02 B
Marketcap
โ‚น98.99
Share price
5.36%
Change (1 day)
-69.01%
Change (1 year)

Revenue for Ovid Therapeutics (OVID)

Revenue in 2024 (TTM): โ‚น47.27 M

According to Ovid Therapeutics 's latest financial reports the company's current revenue (TTM) is โ‚น47.61 M. In 2023 the company made a revenue of โ‚น32.59 M a decrease over the revenue in the year 2022 that were of โ‚น0.12 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ovid Therapeutics from 2016 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น47.27 M45.05%
2023 โ‚น32.59 M-73.79%
2022 โ‚น0.12 B-99.2%
2021 โ‚น15.52 B1585.76%
2020 โ‚น0.92 B
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA